| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c13193fe65025a46525ac2b48f75f12a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00 |
| filingDate |
2003-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2855d167d7ede962158d5141e54340d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1463dc9742944dd6c66da22c67bec709 |
| publicationDate |
2008-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7413748-B2 |
| titleOfInvention |
Transdermal buprenorphine to treat pain in sickle cell crisis |
| abstract |
A specific dosage regimen of buprenorphine achieves pain relief from painful episodes due to sickle cell disease. The dosage regimen comprises administering to a patient in need of pain relief from sickle cell disease at least one BTDS transdermal patch. Alternatively, the dosing regimen comprises administering to the patient ( 1 ) a first buprenorphine-containing transdermal dosage form for a first dosing period; ( 2 ) administering to the patient a second buprenorphine-containing transdermal dosage form for a second dosing period, where the second dosage form comprises the same dosage of buprenorphine as, or a greater dosage of buprenorphine than, the first dosage form; and ( 3 ) administering to the patient a third buprenorphine-containing transdermal dosage form for a third dosing period, where the third dosage form comprises a greater dosage of buprenorphine than the second dosage form. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014122627-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10085964-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9801849-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9820964-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11052066-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10154986-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3851101-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017056393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10369131-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015157625-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9642850-B2 |
| priorityDate |
2002-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |